Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

Angelo Zullo; Enzo Ierardi; Cesare Hassan; Vincenzo De Francesco

doi:10.4103/1319-3767.91729

Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

Angelo Zullo, Enzo Ierardi, Cesare Hassan, Vincenzo De Francesco

Risultato della ricerca: Contributo in rivista › Articolo in rivista

27 Citazioni (Scopus)

Abstract

Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do exist in using furazolidone.

Lingua originale	English
pagine (da-a)	11-17
Numero di pagine	7
Rivista	Saudi Journal of Gastroenterology
Volume	18
DOI	https://doi.org/10.4103/1319-3767.91729
Stato di pubblicazione	Pubblicato - 2012
Pubblicato esternamente	Sì

Keywords

Anti-Infective Agents, Local
Drug Resistance, Bacterial
Drug Therapy, Combination
Furazolidone
Helicobacter Infections
Helicobacter pylori
Humans

Accesso al documento

10.4103/1319-3767.91729

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{180d2a1bd972433daea3620f68e5643b,

title = "Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis",

abstract = "Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do exist in using furazolidone.",

keywords = "Anti-Infective Agents, Local, Drug Resistance, Bacterial, Drug Therapy, Combination, Furazolidone, Helicobacter Infections, Helicobacter pylori, Humans, Anti-Infective Agents, Local, Drug Resistance, Bacterial, Drug Therapy, Combination, Furazolidone, Helicobacter Infections, Helicobacter pylori, Humans",

author = "Angelo Zullo and Enzo Ierardi and Cesare Hassan and {De Francesco}, Vincenzo",

year = "2012",

doi = "10.4103/1319-3767.91729",

language = "English",

volume = "18",

pages = "11--17",

journal = "Saudi Journal of Gastroenterology",

issn = "1319-3767",

publisher = "Riyaḍ: Saudi Society of Gastroenterology.",

}

TY - JOUR

T1 - Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

AU - Zullo, Angelo

AU - Ierardi, Enzo

AU - Hassan, Cesare

AU - De Francesco, Vincenzo

PY - 2012

Y1 - 2012

N2 - Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do exist in using furazolidone.

AB - Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do exist in using furazolidone.

KW - Anti-Infective Agents, Local

KW - Drug Resistance, Bacterial

KW - Drug Therapy, Combination

KW - Furazolidone

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

KW - Anti-Infective Agents, Local

KW - Drug Resistance, Bacterial

KW - Drug Therapy, Combination

KW - Furazolidone

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Humans

UR - http://hdl.handle.net/10807/35636

U2 - 10.4103/1319-3767.91729

DO - 10.4103/1319-3767.91729

M3 - Article

SN - 1319-3767

VL - 18

SP - 11

EP - 17

JO - Saudi Journal of Gastroenterology

JF - Saudi Journal of Gastroenterology

ER -

Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo